drugset / Trial / NCT00805064
Combined Triple Procedure in Retinal Vein Occlusion (RVO)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of this pilot study was to investigate the effects of an intravitreal combination therapy using triamcinolone and bevacizumab in patients with retinal vein occlusion (RVO).
Timeline
- Start
- 2006-01
- Primary completion
- 2007-12
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bevacizumab | Monoclonal antibody | 1.25 mg | Intravitreal |
| Comparator | Triamcinolone | Other / unclassified | 8 mg | Intravitreal |